Literature DB >> 35860818

A Case of Alport Syndrome Associated with Recurrent Stanford Type B Aortic Dissections.

Miki Takeda1, Tadanori Minagawa1, Wakiko Hiranuma1, Takayuki Matsuoka1, Takuya Shimizu1, Shunsuke Kawamoto1.   

Abstract

Alport syndrome is often characterized by renal dysfunction and hearing loss due to abnormalities in type IV collagen production. In this study, we report a rare case of recurrent aortic dissections that developed in a young patient with Alport syndrome over a short period. We discuss the associations between Alport syndrome and aortic dissection with a literature review and emphasize the need for regular follow-up of patients with Alport syndrome for early detection of aortic disease.
© 2022 The Editorial Committee of Annals of Vascular Diseases.

Entities:  

Keywords:  Alport syndrome; Stanford type B aortic dissection; renal failure

Year:  2022        PMID： 35860818      PMCID： PMC9257394          DOI： 10.3400/avd.cr.22-00010

Source DB:  PubMed          Journal:  Ann Vasc Dis        ISSN： 1881-641X


  7 in total

1.  Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy.

Authors:  Oliver Gross; Christoph Licht; Hans J Anders; Bernd Hoppe; Bodo Beck; Burkhard Tönshoff; Britta Höcker; Simone Wygoda; Jochen H H Ehrich; Lars Pape; Martin Konrad; Wolfgang Rascher; Jörg Dötsch; Dirk E Müller-Wiefel; Peter Hoyer; Bertrand Knebelmann; Yves Pirson; Jean-Pierre Grunfeld; Patrick Niaudet; Pierre Cochat; Laurence Heidet; Said Lebbah; Roser Torra; Tim Friede; Katharina Lange; Gerhard A Müller; Manfred Weber
Journal:  Kidney Int       Date:  2011-12-14       Impact factor: 10.612

2.  The NC1 domain of collagen IV encodes a novel network composed of the alpha 1, alpha 2, alpha 5, and alpha 6 chains in smooth muscle basement membranes.

Authors:  D B Borza; O Bondar; Y Ninomiya; Y Sado; I Naito; P Todd; B G Hudson
Journal:  J Biol Chem       Date:  2001-05-25       Impact factor: 5.157

3.  Aortic abnormalities in males with Alport syndrome.

Authors:  Clifford E Kashtan; Yoav Segal; Frances Flinter; David Makanjuola; Jay-Sen Gan; Terry Watnick
Journal:  Nephrol Dial Transplant       Date:  2010-05-21       Impact factor: 5.992

4.  Aortic dissection in young patients with chronic hypertension.

Authors:  B A Vogt; P E Birk; V Panzarino; S H Hite; C E Kashtan
Journal:  Am J Kidney Dis       Date:  1999-02       Impact factor: 8.860

5.  Ruptured thoracoabdominal aortic aneurysm in a renal transplant patient with Alport's syndrome.

Authors:  O T A Lyons; E R C St John; J P Morales; Y C Chan; P R Taylor
Journal:  Ann Vasc Surg       Date:  2007-08-13       Impact factor: 1.466

6.  Safety and Efficacy of the ACE-Inhibitor Ramipril in Alport Syndrome: The Double-Blind, Randomized, Placebo-Controlled, Multicenter Phase III EARLY PRO-TECT Alport Trial in Pediatric Patients.

Authors:  Oliver Gross; Tim Friede; Reinhard Hilgers; Anke Görlitz; Karsten Gavénis; Raees Ahmed; Ulrike Dürr
Journal:  ISRN Pediatr       Date:  2012-07-01

Review 7.  A review of clinical characteristics and genetic backgrounds in Alport syndrome.

Authors:  Kandai Nozu; Koichi Nakanishi; Yoshifusa Abe; Tomohiro Udagawa; Shinichi Okada; Takayuki Okamoto; Hiroshi Kaito; Katsuyoshi Kanemoto; Anna Kobayashi; Eriko Tanaka; Kazuki Tanaka; Taketsugu Hama; Rika Fujimaru; Saori Miwa; Tomohiko Yamamura; Natsusmi Yamamura; Tomoko Horinouchi; Shogo Minamikawa; Michio Nagata; Kazumoto Iijima
Journal:  Clin Exp Nephrol       Date:  2018-08-20       Impact factor: 2.801
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.